Drug
Suramin clinical trials
Also written Bayer 205.
- studies test it
- 19
- open now
- 1
- in phase 3
- 2
- first study started
- 1990
Keep track of what changes. Save the Suramin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
19 studies that test it; most in 1995 (2)
| Year | Studies |
|---|---|
| 1990 | 1 |
| 1994 | 1 |
| 1995 | 2 |
| 1996 | 2 |
| 1997 | 2 |
| 1999 | 1 |
| 2000 | 2 |
| 2002 | 1 |
| 2004 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 13
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 17
National Cancer Institute (NCI) (6) · Rediscovery Life Sciences (1) · Paxmedica (1) · University of Wisconsin, Madison (1) · University of California, San Diego (1) · Cancer Research UK (1) · Emory University (1) · University of Arkansas (1)
Often tested with
Tested in the same studies.
Paclitaxel (2) · Fluorouracil (1) · Carboplatin (1) · Doxorubicin (1) · Flutamide (1)
Studies
Open first, then newest update. How each study uses Suramin is read from its arms, and is right about nine times in ten.
Testing it · 19
- Suramin for the Treatment of Autism Trial: KZ101 in a Male Pediatric Population With Autism Spectrum Disorder (ASD)RecruitingPhase 2Children's Hospital of Orange CountyNCT06866275Written as KZ101
- Double Blind Trial in Children With Autism Spectrum DisorderCompletedPhase 2PaxmedicaNCT06058962Written as Suramin Sodium
- Study of Suramin in Subjects With Furosemide-Resistant AKIActive, not recruitingPhase 2Rediscovery Life SciencesNCT04496596Written as Suramin
- Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung CancerCompletedPhase 2University of Wisconsin, MadisonNCT01671332Written as Suramin
- University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) TrialCompletedPhase 1/2University of California, San DiegoNCT02508259Written as Suramin
- Study to Evaluate the Tolerance and Pharmacokinetics of Suramin SodiumStatus unknownPhase 1First Affiliated Hospital of Zhejiang UniversityNCT03804749Written as suramin sodium
- Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) CancerCompletedPhase 1/2National Cancer Institute (NCI)NCT00083109Written as Suramin
- Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast CancerCompletedPhase 1/2National Cancer Institute (NCI)NCT00054028Written as suramin
- Suramin in Treating Patients With Recurrent Bladder CancerCompletedPhase 1Cancer Research UKNCT00006476Written as suramin
- Suramin in Treating Patients With Recurrent Primary Brain TumorsCompletedPhase 2Emory UniversityNCT00002639Written as suramin
- Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedPhase 2National Cancer Institute (NCI)NCT00006929Written as suramin
- Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate CancerCompletedPhase 3National Cancer Institute (NCI)NCT00002723Written as suramin
- Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's DiseaseCompletedPhase 2University of ArkansasNCT00002652Written as suramin
- S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by SurgeryTerminatedPhase 2SWOG Cancer Research NetworkNCT00002921Written as suramin
- Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedPhase 2Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT00004073Written as suramin
- Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid TumorsCompletedPhase 1Mayo ClinicNCT00003038Written as suramin
- Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate CancerCompletedPhase 3Eastern Cooperative Oncology GroupNCT00002881Written as suramin
- A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate CarcinomaCompletedPhase 2National Cancer Institute (NCI)NCT00001266Written as Suramin
- A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the BladderCompletedPhase 1National Cancer Institute (NCI)NCT00001381Written as suramin
Given in every arm · 1 — Suramin is usual care beside what is tested
Codes
What other systems call Suramin · ClinicalTrials.gg INT008263
- MeSH (NLM) D013498SuraminConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 6032D45BEMSURAMINConfirmed FDA, NLM, Wikidata
- RxNorm 10256Confirmed FDA, Wikidata
- Wikidata Q425946suraminConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C853SuraminOne source FDA
- DrugBank DB04786One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D013498 | Suramin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 6032D45BEM | SURAMIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 10256 | — | Confirmed FDA, Wikidata |
| Wikidata | Q425946 | suramin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C853 | Suramin | One source FDA |
| DrugBank | DB04786 | — | One source Wikidata |
Also registered as suramin sodium (UNII 89521262IH).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.